A multicenter, randomized, double-blind, placebo-controlled trial of deferasirox (Exjade) in patients with low/intermediate-1 risk MDS and transfusional iron overload

• Angelucci E ;
• Bowen D ;
• Magalhaes SMM ;
• Lawniczek T ;
• Douma S ;
• Jakobs P ;
• Garcia-Manero G